Use this URL to cite or link to this record in EThOS:
Title: Linkage between industrial and academic research : The case of biotechnological research in the pharmaceutical industry.
Author: Faulkner, W.
ISNI:       0000 0001 3458 345X
Awarding Body: University of Sussex
Current Institution: University of Sussex
Date of Award: 1986
Availability of Full Text:
Access from EThOS:
This thesis is a study of research linkage between industry and academia. It concentrates on the industrial side of these interactions and, in particular, the impact of information flows from academia industrial innovation. Specifically, the study explores the proposition that linkage varies - in extent and nature according to the stage of development of the research field involved. A review of the literature suggested that linkage should be particularly strong in a nascent technology, such as that unfolding currently in biotechnology. The field study involved face-to-face interviews with industrial researchers from UK pharmaceutical companies and from new start-up companies. It was designed in order to ascertain the relative strength of linkages in the new biotechnology; to characterize these linkages; and to explore how they might change as the technology develops. It is ~emonstrated that linkage is indeed strong here, involving lntensive 'search' activities and often substantial formal collaboration with academia. The background material collected - concerning the role of linkage in innovation and in corporate strategies for biotechnology confirm that companies are obliged to 'plug in' to academic research precisely because 'of the dynamism and uncertainty which characterizes a new technological field. It is argued that those pharmaceutical companies which are interacting most with academic research are also those which are most likely to succeed commercially with the new techniques. The start-up companies in biotechnology are shown to have extremely close links with both academia and the large established companies active in the field. It is argued that the very presence of such companies is itself symptomatic of the proximity of academic science and industrial technology in this new field. In conclusion, it is suggested that the pattern of linkage found in biotechnology may well ~ertain in other new science-based fields; some policy lmplications are discussed.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available
Keywords: Pharmacology & pharmacy & pharmaceutical chemistry